Granite Point's Q4: A Beat on Paper, But the Market Priced in More

The core tension in Granite Point's report is a classic case of expectations versus reality. The company posted a fourth-quarter earnings per share of -$0.06, which beat the consensus estimate by a significant 69.7%. On paper, that's a clear positive surprise. Yet the market's reaction was a sell-off, with the stock falling 7.49% in premarket trading.

This dynamic highlights what's already priced in. While the EPS beat was a relief, the market was focused on other, more concerning signals that were already baked into the share price. The revenue miss was stark, coming in at $7.47 million against a forecast of $10.4 million, a shortfall of 28.17%. More critically, the GAAP net loss was substantial at -$0.58 per share, driven by a $14.4 million credit loss provision and a $6.8 million REO impairment. This paints a picture of a company under pressure, with its book value per share declining to $7.29.

The whisper number, it seems, was about the quality of the earnings and the forward trajectory, not just the bottom-line EPS figure. The market was already braced for a loss and a shrinking portfolio, as management expects portfolio contraction through mid-2026. The real disappointment was the lack of a clear path to growth or resolution in the near term.

The guidance to resume new originations only in the second half of 2026, while logical, does little to offset the current quarter's weak performance and elevated credit risk, with the CECL reserve rising to $148 million.

In short, the EPS beat was a minor relief, but it was drowned out by the broader narrative of operational weakness and a stretched balance sheet. The stock fell because the reality of the report confirmed the market's worst fears about the company's near-term financial health, even as it slightly missed the low bar for earnings.

Portfolio Reality Check: Book Value Decline and Rising Reserves

For a mortgage REIT, the health of the portfolio is the bottom line. Granite Point's fourth quarter delivered a harsh reality check on that front. The company's book value per share fell to $7.29, a direct hit to shareholder equity. This decline wasn't just a minor blip; it was driven by two significant impairment charges that underscore the ongoing stress in the portfolio.

The first major hit was a $14.4 million credit loss provision, which alone accounted for a large portion of the quarter's GAAP net loss. This provision is a clear signal that the company is recognizing losses on loans that are underperforming or facing deterioration. The second charge, a $6.8 million REO impairment, points to problems with properties the company has taken back through foreclosure. These two items combined to create a material drag on the balance sheet.

The risk profile is further highlighted by the company's credit loss reserve. The CECL reserve rose to approximately $148 million, a figure that represents the market's concerns about future losses. Within that reserve, there are four loans rated as "5"-the highest risk category-with a total principal balance of about $249 million. This concentration of high-risk assets is a key vulnerability that the market was already pricing in, making the quarter's provisions feel like a confirmation rather than a surprise.

The bottom line is that the portfolio contraction management expects through mid-2026 is not a strategic choice but a necessity driven by these credit pressures. The rising reserves and falling book value paint a picture of a company actively resolving problems, but the process is eroding value in the short term. For investors, this is the core of the expectation gap: the market had already discounted the risk, and the quarterly results merely confirmed the ongoing deterioration.

The 2026 Playbook: Resolution, Refinancing, and a Late Re-Entry

Management's 2026 plan is a clear, if cautious, playbook for resolution. The core strategy aligns with the market's expectations: a period of deleveraging and portfolio cleanup before a gradual return to growth. The company expects portfolio contraction through mid-2026, with new originations planned to resume only in the second half of the year. This timeline is logical, given the need to resolve high-risk assets and improve the balance sheet. The market had already priced in this extended period of contraction, so the plan itself isn't a surprise.

The key actions are about efficiency and reducing the cost of capital. Management is prioritizing the resolution of problem loans and reducing higher-cost debt. A concrete early win was cutting the repurchase facility weighted average cost of financing by about 60 bps, which provides a tangible annual savings of about $0.10 per share. This is a direct hit to operating expenses and improves the net interest spread, a critical metric for a mortgage REIT. It's a positive step that shows management is executing on its stated objectives.

The early 2026 results provide some relief. The company has already seen two full loan repayments of $174 million since the quarter ended. This activity, driven by improving CRE credit-market liquidity, is exactly the kind of resolution momentum management highlighted. It reduces risk and begins to shrink the portfolio in a controlled way.

The bottom line is that the plan is consistent with the market's low expectations. There's no grand turnaround narrative here, just a methodical cleanup. The market was braced for a weak quarter and a shrinking book value, and management's guidance confirms that trajectory. The real test will be whether the late-2026 re-entry into originations is truly supported by "improving market conditions," as management hopes. For now, the playbook is about survival and efficiency, not growth.

Catalysts and Risks: What to Watch for the Next Re-rating

The path to a re-rating for Granite Point hinges on a few forward-looking events that will test whether the current low expectations are too pessimistic or justifiable. The primary catalyst is the execution of management's plan to resume new originations in the second half of 2026. For this to drive a positive shift, the deal flow must demonstrate improved quality and pricing, not just a return to activity. The market has already priced in a period of contraction and caution; the re-rating will come only if the company can show it is re-entering the market on better terms.

A key risk is the fate of the remaining portfolio risk. The company's CECL reserve now stands at approximately $148 million, with four loans rated as "5"-the highest risk category-carrying a total principal balance of about $249 million. The early 2026 repayments of $174 million are a positive step, but they do not eliminate this concentration. Any further impairments on these high-risk assets would directly contradict the narrative of a resolved portfolio and likely trigger another sell-off.

Ultimately, the measure of capital preservation and management's success will be the stabilization or growth of book value per share. After a decline to $7.29 in Q4, the stock's trajectory will be dictated by whether the cost-saving actions-like the 60 bps reduction in repurchase facility financing costs-can outweigh future credit losses. If book value stabilizes or begins to climb before the end of 2026, it would signal that the portfolio cleanup is working and that the company is building a stronger foundation for its late re-entry. If it continues to drift lower, the market's current skepticism will be validated.

The setup is clear: watch for signs of a robust deal pipeline in the coming months, monitor the resolution of the "5" loans, and track book value. The stock's next move will be determined by whether these metrics confirm a turning point or merely confirm the ongoing cleanup.